Potential SLC targets for the treatment of metabolic disease with limited evidence based on human studies or mouse models
SLC Name | Protein Name | Substrates | Expression in Metabolically Active Organs | Subcellular Localization | Link to Metabolic Disease in Humans | Link to Metabolic Disease in Mice | References |
---|---|---|---|---|---|---|---|
SLC5A9 | SGLT4 | Mannose, glucose, fructose | Intestine, kidney, liver | Plasma membrane | Diabetic retinopathy | N.A. | Tazawa et al., 2005; Ung et al., 2017 |
SLC5A10 | SGLT5 | Mannose, fructose, glucose, galactose | Kidney | Plasma membrane | N.A. | Hepatic steatosis | Grempler et al., 2012; Fukuzawa et al., 2013 |
SLC13A1 | NaS1, NaSi-1 | Sulfate, thiosulfate, selenate | Kidney, intestine, adrenal glands, adipose tissue | Plasma membrane | Drug-induced hepatotoxicity | Fatty liver | Markovich, 2001; Dawson et al., 2006 |
SLC13A2 | NaDC1, NaC1, SDCT1 | Succinate, α-ketoglutarate, citrate | Kidney, intestine | Plasma membrane | Nephrolithiasis | Nephrolithiasis | Markovich and Murer, 2004; Ho et al., 2007; Bergeron et al., 2013; Udomsilp et al., 2018 |
SLC13A3 | NaDC3, NaC3, SDCT2 | Succinate, α-ketoglutarate, citrate | Kidney, liver, brain | Plasma membrane | Diabetic nephropathy, chronic kidney disease | N.A. | Bento et al., 2008; Ju et al., 2009; Bergeron et al., 2013; Nanayakkara et al., 2014 |
SLC16A3 | MCT4 | Lactate, pyruvate, ketone bodies | Skeletal muscle, brain, intestine | Plasma membrane, nuclear membrane | Diabetic nephropathy | N.A. | Lokman et al., 2011; Halestrap, 2013 |
SLC16A9 | MCT9 | Carnitine | Kidney, adrenal glands | Plasma membrane | Gout | N.A. | Kolz et al., 2009; van der Harst et al., 2010; Halestrap, 2013; Nakayama et al., 2013 |
SLC16A10 | MCT10, TAT1 | Aromatic amino acids | Skeletal muscle, heart, kidney, intestine, pancreas | Plasma membrane | NAFLD | N.A. | Halestrap, 2013; Lake et al., 2015 |
SLC25A25 | APC2, SCaMC-2, MCSC | Adenine nucleotides, phosphate | Brain, heart, skeletal muscle, liver, intestine, pancreas | Inner mitochondrial membrane | N.A. | Obesity | Anunciado-Koza et al., 2011 |
SLC25A40 | MCFP | Unknown | Liver, kidney, intestine, brain, adrenal glands | Inner mitochondrial membrane | Hypertriglyceridemia | N.A. | Rosenthal et al., 2013 |
SLC30A3 | ZnT3 | Zinc | Brain | Synaptic vesicle | N.A. | Impaired glucose tolerance | Palmiter et al., 1996; Smidt et al., 2009; Keele et al., 2018 |
SLC30A7 | ZnT7 | Zinc | Intestine | Golgi apparatus | N.A. | Obesity, insulin resistance | Kirschke and Huang, 2003; Huang et al., 2007, 2010, 2012, 2018 |